HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marika Collin Selected Research

2-chloro-5-nitrobenzanilide

1/2007Lysophosphatidic acid reduces the organ injury caused by endotoxemia-a role for G-protein-coupled receptors and peroxisome proliferator-activated receptor-gamma.
4/2006Peroxisome proliferator-activated receptor-gamma antagonists GW9662 and T0070907 reduce the protective effects of lipopolysaccharide preconditioning against organ failure caused by endotoxemia.
8/2005The selective PPARgamma antagonist GW9662 reverses the protection of LPS in a model of renal ischemia-reperfusion.
12/2004The peroxisome proliferator-activated receptor-gamma ligand 15-deoxyDelta12,14 prostaglandin J2 reduces the organ injury in hemorrhagic shock.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marika Collin Research Topics

Disease

15Shock
02/2007 - 08/2003
8Inflammation (Inflammations)
02/2007 - 09/2005
7Endotoxemia
01/2007 - 03/2004
4Sepsis (Septicemia)
01/2007 - 09/2005
3Septic Shock (Toxic Shock Syndrome)
02/2007 - 08/2003
3Ischemia
02/2007 - 07/2004
3Hypotension (Low Blood Pressure)
04/2006 - 03/2004
2Reperfusion Injury
01/2007 - 08/2004
2Colitis
01/2007 - 03/2006
2Hemorrhagic Shock
12/2004 - 07/2004
1Arthritis (Polyarthritis)
07/2006
1Experimental Arthritis
07/2006
1Myelitis
07/2006
1Spinal Cord Injuries (Spinal Cord Injury)
07/2006
1Critical Illness (Critically Ill)
05/2006
1Body Weight (Weight, Body)
03/2006
1Tachycardia (Tachyarrhythmias)
10/2005
1Hemorrhage
12/2004
1Lung Injury
11/2004
1Myocardial Ischemia (Ischemic Heart Diseases)
07/2004
1Multiple Organ Failure (MODS)
03/2004

Drug/Important Bio-Agent (IBA)

9Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2007 - 03/2004
8Alanine Transaminase (SGPT)IBA
01/2007 - 03/2004
8PPAR gammaIBA
01/2007 - 08/2003
7CreatinineIBA
04/2006 - 03/2004
6LigandsIBA
04/2006 - 08/2003
5Glycogen Synthase (Synthase I)IBA
02/2007 - 03/2006
5Glycogen Synthase Kinase 3 betaIBA
01/2007 - 09/2005
5Creatine Kinase (Creatine Phosphokinase)IBA
01/2007 - 03/2004
42-chloro-5-nitrobenzanilideIBA
01/2007 - 12/2004
4LipopolysaccharidesIBA
01/2007 - 08/2005
4Lipase (Acid Lipase)FDA Link
10/2005 - 03/2004
4Indicators and Reagents (Reagents)IBA
10/2005 - 03/2004
3Peroxidase (Myeloperoxidase)IBA
07/2006 - 11/2004
34- benzyl- 2- methyl- 1,2,4- thiadiazolidine- 3,5- dioneIBA
07/2006 - 03/2006
3EndotoxinsIBA
08/2005 - 02/2004
3PPAR-gamma AgonistsIBA
12/2004 - 08/2003
39-deoxy-delta-9-prostaglandin D2IBA
12/2004 - 08/2003
3TransferasesIBA
11/2004 - 03/2004
3BilirubinIBA
11/2004 - 03/2004
2Glycogen Synthase KinasesIBA
02/2007 - 01/2007
2Insulin (Novolin)FDA Link
02/2007 - 05/2006
2Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
04/2006 - 08/2005
2Hydrogen Sulfide (Sulfide, Hydrogen)IBA
12/2005 - 10/2005
2Urea (Carbamide)FDA LinkGeneric
12/2004 - 08/2004
1Glycogen Synthase Kinase 3IBA
02/2007
1HDL LipoproteinsIBA
01/2007
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2007
1lysophosphatidic acidIBA
01/2007
1Lipoproteins (Lipoprotein)IBA
01/2007
13- (4- (4- ((1- (2- chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acidIBA
01/2007
1LipidsIBA
01/2007
13-nitrotyrosineIBA
07/2006
11- stearoyl- 2- linoleoylphosphatidylcholineIBA
07/2006
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
07/2006
1EmulsionsIBA
07/2006
1Freund's AdjuvantIBA
07/2006
1Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
07/2006
1Collagen Type II (Type II Collagen)IBA
07/2006
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
07/2006
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
07/2006
1Blood Glucose (Blood Sugar)IBA
05/2006
1parecoxibIBA
04/2006
1T 0070907IBA
04/2006
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
04/2006
1Interleukin-1beta (Interleukin 1 beta)IBA
04/2006
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
04/2006
13- (3- chloro- 4- hydroxyphenylamino)- 4- (4- nitrophenyl)- 1H- pyrrole- 2,5- dioneIBA
03/2006
1AcidsIBA
03/2006
1SulfitesIBA
12/2005
1Cystathionine gamma-Lyase (Cysteine Desulfhydrase)IBA
10/2005
1Cystathionine beta-Synthase (Serine Sulfhydrase)IBA
10/2005
1propargylglycineIBA
10/2005
1EnzymesIBA
10/2005
1IP 24IBA
08/2005
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
12/2004
115-deoxyprostaglandin J2IBA
12/2004
1zileuton (Zyflo)FDA Link
11/2004
1Alkaline PhosphataseIBA
11/2004
1Lipoxygenase InhibitorsIBA
11/2004
1AmylasesFDA Link
11/2004
1Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
11/2004
1UrocortinsIBA
08/2004
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
07/2004
1Thiopental (Pentothal)FDA Link
07/2004
1ErythropoietinFDA Link
07/2004
1Adenosine Triphosphate (ATP)IBA
07/2004
1Caspase 3 (Caspase-3)IBA
07/2004

Therapy/Procedure

7Therapeutics
02/2007 - 08/2003
2Resuscitation
12/2004 - 07/2004
1Laminectomy
07/2006
1Critical Care (Surgical Intensive Care)
09/2004